A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukaemia applicable to patients treated with novel therapies and standard of care Meeting Abstract
| Authors: | Hillmen, P.; Soumerai, J.; Zelenetz, A.; Darif, M.; Londhe, A.; Xing, G.; Huang, J.; Lin, M.; Byrd, J.; Chanan-Khan, A.; Furman, R.; Hallek, M.; Jones, J.; Sharman, J.; Ferrante, L.; Reddy, V.; Dreiling, L.; Adewoye, H.; Dubowy, R.; Howes, A.; James, D. |
| Abstract Title: | A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukaemia applicable to patients treated with novel therapies and standard of care |
| Meeting Title: | 58th Annual Scientific Meeting of the British Society for Haematology |
| Keywords: | cll; idelalisib; risk model; chronic lymphocytic leukaemia |
| Journal Title: | British Journal of Haematology |
| Volume: | 181 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Apr 16-18 |
| Meeting Location: | Liverpool, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2018-04-01 |
| Start Page: | 75 |
| Language: | English |
| ACCESSION: | WOS:000430117900092 |
| PROVIDER: | wos |
| PUBMED: | 29658101 |
| DOI: | 10.1111/bjh.15226 |
| Notes: | Meeting Abstract: BSH18-PO-061 -- 58th Annual Scientific Meeting of the British-Society-for-Haematology -- APR 16-18, 2018 -- Liverpool, ENGLAND -- 1 -- SI -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
